Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5126]

Monoclonal antibodies and multiple myeloma

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

Monoclonal antibodies and multiple myeloma ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

New definition for multiple myeloma improves patient outcomes

Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA

New definition for multiple myeloma improves patient outcomes ( Prof Vincent Rajkumar - Mayo Clinic, Rochester, USA )

Factors influencing response to blinatumomab in relapsed/refractory ALL

Prof Max Topp - Würzburg University Hospital, Würzburg, Germany

$Factors influencing response to blinatumomab in relapsed/refractory ALL ( Prof Max Topp - Würzburg University Hospital, Würzburg, Germany )$

Evidence for kinase inhibitor activity in acute myeloid leukaemia

Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany

Evidence for kinase inhibitor activity in acute myeloid leukaemia ( Dr Gerhard Ehninger - University Hospital Dresden, Dresden, Germany )

Targeted combination therapy with potential to eliminate relapsed chronic...

Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia

Targeted combination therapy with potential to eliminate relapsed chronic lymphocytic leukaemia ( Dr Andrew Roberts - Royal Melbourne Hospital, Melbourne, Australia )

DNMT3A R882 mutations promote chemoresistance and residual disease in AML

Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA

DNMT3A R882 mutations promote chemoresistance and residual disease in AML ( Dr Olga Guryanova - Memorial Sloan Kettering Cancer Center, New York, USA )

Adding elotuzumab to standard treatment for multiple myeloma significantly...

Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens...

Adding elotuzumab to standard treatment for multiple myeloma significantly reduced the risk of disease progression ( Dr Meletios Dimopoulos - National and Kapodistrian University of Athens, Athens, Greece )

Treatment and survival of patients with chronic myeloid leukaemia in Europe

Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany

Treatment and survival of patients with chronic myeloid leukaemia in Europe ( Dr Verena Hoffmann - Ludwig-Maximilians-Universität, München, Germany )

Expert overview on the recent developments in mantle cell lymphoma

Professor Gordon McVie and Professor Simon Rule

Expert overview on the recent developments in mantle cell lymphoma ( Professor Gordon McVie and Professor Simon Rule )

Round-up of the latest research on lung cancer

Dr James Spicer - Guy's Hospital, London, UK

Round-up of the latest research on lung cancer ( Dr James Spicer - Guy's Hospital, London, UK )

Lenvatinib increases progression free survival when used with everolimus in...

Dr James Larkin - Royal Marsden Hospital, London, UK

Lenvatinib increases progression free survival when used with everolimus in metastatic renal cell carcinoma ( Dr James Larkin - Royal Marsden Hospital, London, UK )

Medically under-represented populations: Refining the calculation of accrual...

Dr Robert Comis - ECOG-ACRIN Cancer Research Group, Philadelphia, USA

Medically under-represented populations: Refining the calculation of accrual targets ( Dr Robert Comis - ECOG-ACRIN Cancer Research Group, Philadelphia, USA )

More from ecancer